Patents by Inventor Carolina Abramovitch

Carolina Abramovitch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IFN receptor 1 binding proteins
    Patent number: 7524928
    Abstract: Novel proteins IR1B1 and IR1B4 have been isolated which bind to the type I IFN receptor IFNAR1 and function in the cellular response to IFNs. DNA encoding such proteins in either the sense or anti-sense orientation can be administered to either enhance or inhibit the cellular response to IFNs. Antibodies to the proteins can be used for isolation of the new protein or for immunodetection thereof.
    Type: Grant
    Filed: February 9, 2006
    Date of Patent: April 28, 2009
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Michel Revel, Carolina Abramovitch, Judith E. Chebath
  • IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
    Patent number: 7264945
    Abstract: Novel proteins IR1B1 and IR1B4 have been isolated which bind to the type I IFN receptor IFNAR1 and function in the cellular response to IFNs. DNA encoding such proteins in either the sense or anti-sense orientation can be administered to either enhance or inhibit the cellular response to IFNs. Antibodies to the proteins can be used for isolation of the new protein or for immunodetection thereof.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: September 4, 2007
    Assignee: Yeda Research and Development Co. Ltd
    Inventors: Michel Revel, Carolina Abramovitch, Judith E. Chebath
  • Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
    Publication number: 20060147436
    Abstract: Novel proteins IR1B1 and IR1B4 have been isolated which bind to the type I IFN receptor IFNAR1 and function in the cellular response to IFNs. DNA encoding such proteins in either the sense or anti-sense orientation can be administered to either enhance or inhibit the cellular response to IFNs. Antibodies to the proteins can be used for isolation of the new protein or for immunodetection thereof.
    Type: Application
    Filed: February 9, 2006
    Publication date: July 6, 2006
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Michel Revel, Carolina Abramovitch, Judith Chebath
  • Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
    Publication number: 20030176678
    Abstract: Novel proteins IR1B1 and IR1B4 have been isolated which bind to the type I IFN receptor IFNAR1 and function in the cellular response to IFNs. DNA encoding such proteins in either the sense or anti-sense orientation can be administered to either enhance or inhibit the cellular response to IFNs. Antibodies to the proteins can be used for isolation of the new protein or for immunodetection thereof.
    Type: Application
    Filed: December 4, 2002
    Publication date: September 18, 2003
    Inventors: Michel Revel, Carolina Abramovitch, Judith E. Chebath
  • Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons
    Publication number: 20020119129
    Abstract: Novel proteins IR1B1 and IR1B4 have been isolated which bind to the type I IFN receptor IFNAR1 and function in the cellular response to IFNs. DNA encoding such proteins in either the sense or anti-sense orientation can be administered to either enhance or inhibit the cellular response to IFNs. Antibodies to the proteins can be used for isolation of the new protein or for immunodetection thereof.
    Type: Application
    Filed: April 1, 2002
    Publication date: August 29, 2002
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Michel Revel, Carolina Abramovitch, Judith E. Chebath